Apixaban Shows No Increased Risk of MRI-Detected Intracranial Hemorrhage Compared to Aspirin in Atrial Cardiopathy
An exploratory analysis from the ARCADIA-MRI substudy reveals that apixaban carries a similar risk of incident intracranial hemorrhages, microbleeds, and superficial siderosis compared to aspirin in patients with atrial cardiopathy and cryptogenic stroke.